Blueprint Medicines Corp (NASDAQ: BPMC) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.79 versus a loss $-1.82 for the same period a year ago. Relative to the consensus estimate […]
For its fourth fiscal quarter (ending December 31), Agios Pharmaceuticals Inc (NASDAQ: AGIO) has reported E.P.S. of $-1.69 compared to $-1.72 a year ago. Relative to the consensus estimate of $-1.63, this was a shortfall […]
Yelp Inc (NYSE: YELP) has reported E.P.S. of $0.64 for its fourth fiscal quarter (ending December 31) versus $0.40 for the same period a year ago — an increase of 60%. Relative to the consensus […]
Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) has reported a loss for its fourth fiscal quarter (ending December 31) of $-1.39 versus a loss $-1.52 for the same period a year ago. This result fell short of […]
For its first fiscal quarter (ending December 31), Sally Beauty Holdings Inc (NYSE: SBH) has reported a 67% increase in E.P.S. from $0.36 a year ago to $0.60 in the current quarter. This performance was […]
PPL Corp (NYSE: PPL) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.24 versus $0.15 for the same period a year ago — an increase of 60%. However, this result fell […]
For its fourth fiscal quarter (ending December 31), PDF Solutions Inc (NASDAQ: PDFS) has reported a -50% decline in E.P.S. from $0.02 a year ago to $0.01 in the current quarter. This performance was $-0.20 […]
GoDaddy Inc (NYSE: GDDY) has reported E.P.S. of $1.40 for its fourth fiscal quarter (ending December 31) versus $7.88 for the same period a year ago — a decline of -82%. Relative to the consensus […]
DEERE & COMPANY (NYSE: DE) has reported E.P.S. of $3.20 for its first fiscal quarter (ending January 31) versus $6.25 for the same period a year ago — a decline of -49%. Relative to the […]
Crocs Inc (NASDAQ: CROX) has reported E.P.S. of $6.40 for its fourth fiscal quarter (ending December 31) versus $4.19 for the same period a year ago — an increase of 53%. This result exceeded the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research